Literature DB >> 18929943

Pathoetiological model of delirium: a comprehensive understanding of the neurobiology of delirium and an evidence-based approach to prevention and treatment.

José R Maldonado1.   

Abstract

Delirium is the most common complication found in the general hospital setting. Yet, we know relatively little about its actual pathophysiology. This article contains a summary of what we know to date and how different proposed intrinsic and external factors may work together or by themselves to elicit the cascade of neurochemical events that leads to the development delirium. Given how devastating delirium can be, it is imperative that we better understand the causes and underlying pathophysiology. Elaborating a pathoetiology-based cohesive model to better grasp the basic mechanisms that mediate this syndrome will serve clinicians well in aspiring to find ways to correct these cascades, instituting rational treatment modalities, and developing effective preventive techniques.

Entities:  

Mesh:

Year:  2008        PMID: 18929943     DOI: 10.1016/j.ccc.2008.06.004

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  71 in total

1.  Current approaches to the recognition and treatment of alcohol withdrawal and delirium tremens: "old wine in new bottles" or "new wine in old bottles".

Authors:  Theodore A Stern; Anne F Gross; Thomas W Stern; Shamim H Nejad; Jose R Maldonado
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

Review 2.  Delirium in elderly people.

Authors:  Sharon K Inouye; Rudi G J Westendorp; Jane S Saczynski
Journal:  Lancet       Date:  2013-08-28       Impact factor: 79.321

Review 3.  Postoperative Delirium in the Geriatric Patient.

Authors:  Katie J Schenning; Stacie G Deiner
Journal:  Anesthesiol Clin       Date:  2015-07-07

4.  Duration of Agitation, Fluctuations of Consciousness, and Associations with Outcome in Patients with Subarachnoid Hemorrhage.

Authors:  Michael E Reznik; Ali Mahta; J Michael Schmidt; Hans-Peter Frey; Soojin Park; David J Roh; Sachin Agarwal; Jan Claassen
Journal:  Neurocrit Care       Date:  2018-08       Impact factor: 3.210

Review 5.  Management of delirium in palliative care: a review.

Authors:  Luigi Grassi; Augusto Caraceni; Alex J Mitchell; Maria Giulia Nanni; Maria Alejandra Berardi; Rosangela Caruso; Michelle Riba
Journal:  Curr Psychiatry Rep       Date:  2015-03       Impact factor: 5.285

Review 6.  [Delirium in stroke patients : Critical analysis of statistical procedures for the identification of risk factors].

Authors:  P Nydahl; N G Margraf; A Ewers
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-01-31       Impact factor: 0.840

7.  Length of red cell unit storage and risk for delirium after cardiac surgery.

Authors:  Charles H Brown; Maura Grega; Ola A Selnes; Guy M McKhann; Ashish S Shah; Andrew LaFlam; William J Savage; Steven M Frank; Charles W Hogue; Rebecca F Gottesman
Journal:  Anesth Analg       Date:  2014-08       Impact factor: 5.108

8.  A Role for the Adenosine ADORA2B Receptor in Midazolam Induced Cognitive Dysfunction.

Authors:  Jennifer Gile; Yoshimasa Oyama; Sydney Shuff; Tobias Eckle
Journal:  Curr Pharm Des       Date:  2020       Impact factor: 3.116

9.  Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial.

Authors:  Valerie J Page; E Wesley Ely; Simon Gates; Xiao Bei Zhao; Timothy Alce; Ayumi Shintani; Jim Jackson; Gavin D Perkins; Daniel F McAuley
Journal:  Lancet Respir Med       Date:  2013-08-21       Impact factor: 30.700

10.  DEL-FINE: a new tool for assessing the delirogenic properties of drugs of relevance for European pharmacotherapy.

Authors:  Birgit Böhmdorfer; Sonja Rohleder; Martin Wawruch; T J M van der Cammen; Thomas Frühwald; Christian Jagsch; Susanne Melitta Maria Janowitz; Marietta Nagano; Mirko Petrovic; Ulrike Sommeregger; Bernhard Iglseder
Journal:  Z Gerontol Geriatr       Date:  2015-08-19       Impact factor: 1.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.